The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Bone turnover markers at 3 months of aromatase inhibitor therapy for prediction of 1-year bone mineral density loss: The B-ABLE cohort.
Ignacio Tusquets
No relevant relationships to disclose
Sonia Servitja
No relevant relationships to disclose
Dani Prieto-Alhambra
No relevant relationships to disclose
Elisabet Torres
No relevant relationships to disclose
Laia Garrigos
No relevant relationships to disclose
Tamara Martos
No relevant relationships to disclose
Maria Rodriguez-Sanz
No relevant relationships to disclose
Adolf Diez-Perez
No relevant relationships to disclose
Joan Albanell
No relevant relationships to disclose
Xavi Nogues
No relevant relationships to disclose